Fate Therapeutics
FATE
#6665
Rank
NZ$0.73 B
Marketcap
$6.47
Share price
3.09%
Change (1 day)
64.65%
Change (1 year)

EPS for Fate Therapeutics (FATE)

EPS in 2023 (TTM): -$3.62

According to Fate Therapeutics 's latest financial reports the company's current EPS (TTM) is -$3.51. In 2022 the company made an earnings per share (EPS) of -$4.70 a decrease over its 2021 EPS that were of -$3.60.

EPS history for Fate Therapeutics from 2013 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$3.62-22.97%
2022-$4.7030.49%
2021-$3.607.21%
2020-$3.3645.45%
2019-$2.3119.17%
2018-$1.9417.65%
2017-$1.65-3.77%
2016-$1.71-12.4%
2015-$1.96-3.97%
2014-$2.04-2.09%
2013-$2.08

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-$12.66 260.83%๐Ÿ‡บ๐Ÿ‡ธ USA
$8.97-355.76%๐Ÿ‡บ๐Ÿ‡ธ USA
-$13.98 298.62%๐Ÿ‡บ๐Ÿ‡ธ USA
-$5.01 42.86%๐Ÿ‡บ๐Ÿ‡ธ USA
$3.17-190.32%๐Ÿ‡บ๐Ÿ‡ธ USA